...
首页> 外文期刊>Journal of Endodontics: Official Journal of American Association of Endodontists >Anesthetic efficacy of combinations of 0.5 mol/L mannitol and lidocaine with epinephrine for inferior alveolar nerve blocks in patients with symptomatic irreversible pulpitis
【24h】

Anesthetic efficacy of combinations of 0.5 mol/L mannitol and lidocaine with epinephrine for inferior alveolar nerve blocks in patients with symptomatic irreversible pulpitis

机译:0.5 mol / L甘露醇和利多卡因联合肾上腺素对有症状的不可逆性牙髓炎患者的下牙槽神经阻滞的麻醉效果

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: The purpose of these 2 prospective, randomized, single-blind studies was to determine the anesthetic efficacy of lidocaine with epinephrine compared with a combination lidocaine with epinephrine plus 0.5 mol/L mannitol for inferior alveolar nerve (IAN) blocks in patients experiencing symptomatic irreversible pulpitis. Methods: In study one, 55 emergency patients randomly received IAN blocks by using a 3.18-mL formulation containing 63.6 mg of lidocaine with 31.8 μg epinephrine or a 5-mL formulation containing 63.6 mg of lidocaine with 31.8 μg epinephrine (3.18 mL) plus 1.82 mL of 0.5 mol/L mannitol. In study two, 51 emergency patients randomly received IAN blocks by using a 1.9-mL formulation containing 76.4 mg of lidocaine with 36 μg epinephrine or a 3-mL formulation containing 76.4 mg of lidocaine with 36 μg epinephrine (1.9 mL) plus 1.1 mL of 0.5 mol/L mannitol. Endodontic access was begun 15 minutes after the IAN block, and all patients had profound lip numbness. Success was defined as no or mild pain (visual analogue scale recordings) on endodontic access or instrumentation. Results: The 1.9 mL of lidocaine (76.4 mg) with epinephrine plus 0.5 mol/L mannitol had a significantly (P =.04) better success rate of 39% when compared with the lidocaine formulation without mannitol (13% success rate). Conclusions: For mandibular posterior teeth in patients with symptomatic irreversible pulpitis, the addition of 0.5 mol/L mannitol to 1.9 mL of lidocaine (76.4 mg) with epinephrine resulted in a statistically higher success rate. However, the combination lidocaine/mannitol formulation would not result in predictable pulpal anesthesia.
机译:简介:这两项前瞻性,随机,单盲研究的目的是确定利多卡因与肾上腺素的比较,并比较利多卡因与肾上腺素加0.5 mol / L甘露醇对有症状患​​者的下牙槽神经(IAN)的麻醉效果不可逆的牙髓炎。方法:在一项研究中,55名紧急患者随机接受IAN阻滞剂,方法是使用含有63.6 mg利多卡因和31.8μg肾上腺素的3.18 mL制剂或含有63.6 mg利多卡因和31.8μg肾上腺素(3.18 mL)加1.82的5 mL制剂mL的0.5 mol / L甘露醇。在研究2中,有51名急诊患者通过使用1.9mL含76.4 mg利多卡因和36μg肾上腺素的制剂或3mL含76.4 mg利多卡因和36μg肾上腺素(1.9 mL)加1.1 mL的肾上腺素随机接受IAN阻滞0.5 mol / L甘露醇。 IAN阻滞后15分钟开始进行牙髓治疗,所有患者均出现严重的唇部麻木。成功定义为在牙髓接触或使用器械时无疼痛或轻度疼痛(视觉模拟量表记录)。结果:与不含甘露醇的利多卡因制剂(成功率为13%)相比,含肾上腺素加0.5 mol / L甘露醇的1.9 mL利多卡因(76.4 mg)具有39%的显着(P = .04)更好的成功率。结论:对于有症状的不可逆性牙髓炎患者的下颌后牙,在1.9mL利多卡因(76.4 mg)中加入0.5 mol / L甘露醇和肾上腺素,具有统计学上较高的成功率。但是,利多卡因/甘露醇的组合制剂不会导致可预测的牙髓麻醉。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号